Ryan D. Maynard
2008
In 2008, Ryan D. Maynard earned a total compensation of $1.7M as Executive Vice President, Chief Financial Officer at Rigel Pharmaceuticals, a 40% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,426,643 |
|---|---|
| Salary | $300,000 |
| Other | $506 |
| Total | $1,727,149 |
Maynard received $1.4M in option awards, accounting for 83% of the total pay in 2008.
Maynard also received $300K in salary and $506 in other compensation.
Rankings
In 2008, Ryan D. Maynard's compensation ranked 2,815th out of 9,135 executives tracked by ExecPay. In other words, Maynard earned more than 69.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,815 out of 9,135 | 69th |
Division Manufacturing | 1,004 out of 3,436 | 71st |
Major group Chemicals And Allied Products | 176 out of 815 | 78th |
Industry group Drugs | 105 out of 597 | 82nd |
Industry Pharmaceutical Preparations | 80 out of 408 | 80th |
Source: SEC filing on April 4, 2011.
Maynard's colleagues
We found four more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2008.
2008
James Gower
Rigel Pharmaceuticals
Chief Executive Officer
2008
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2008
Elliott Grossbard
Rigel Pharmaceuticals
Chief Medical Officer
2008
Raul Rodriguez
Rigel Pharmaceuticals